JJIJ
TCON

Johnson & Johnson Innovation - JJDC’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$545K Hold
4,200
– – 0.06% 17
2021
Q1 		$691K Hold
4,200
– – 0.09% 14
2020
Q4 		$983K Hold
4,200
– – 0.13% 12
2020
Q3 		$434K Hold
4,200
– – 0.09% 13
2020
Q2 		$165K Hold
4,200
– – 0.03% 15
2020
Q1 		$143K Hold
4,200
– – 0.08% 12
2019
Q4 		$197K Buy
+4,200
New +$276K 0.07% 11

Other funds holding TCON

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's TCON Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q2 2021 at 4,200 shares worth $545K. The position accounts for 0.06% of the portfolio, ranked #17.

Johnson & Johnson Innovation - JJDC first reported a position in TCON in Q4 2019 and has held it in 7 quarters since. The position peaked at $983K in Q4 2020. 44 funds tracked by Wall St. Rank hold TCON as of Q2 2021.

  • Johnson & Johnson Innovation - JJDC held 4,200 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $545K as of Q2 2021.
  • Johnson & Johnson Innovation - JJDC left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q2 2021.
  • TRACON Pharmaceuticals, Inc. Common Stock made up 0.06% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #17 holding.
  • Johnson & Johnson Innovation - JJDC first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2019 and has held it in 7 quarters since.
  • Johnson & Johnson Innovation - JJDC's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $983K in Q4 2020.
  • 44 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.